The US Food and Drug Administration intends to put a “black box” warning on Covid-19 vaccines, according to two people ...
Here's your look at the Zlín City: Arch Moderna announcement trailer for this upcoming cozy, historically inspired city-builder. Join developer Polyperfect for a behind-the-scenes look at the creation ...
A number of diseases tend to peak in the winter, thanks to indoor gatherings that help germs spread. The list includes not ...
Nov 19 (Reuters) - Moderna (MRNA.O), opens new tab said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a major step in strengthening the ...
Moderna, an mRNA specialist known for its COVID-19 vaccine Spikevax, is winding down development of three clinical mRNA programs, including two investigational vaccines for infectious diseases. The ...
With much of Moderna’s rise in this decade tied to its COVID-19 vaccine, the company has struggled in recent years to match the sales highs it experienced during the pandemic. Now, in an effort to ...
With a $140 million investment, Moderna will bring its drug product manufacturing to the United States, joining a parade of drugmakers looking to strengthen their supply chains and reduce exposure to ...
Moderna (MRNA) announced on Wednesday that it has completed its domestic end-to-end mRNA manufacturing network with the onshoring of drug product manufacturing to its Moderna Technology Center in ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Moderna's chief technical ...
Shares of Moderna, Inc. (NASDAQ: MRNA) are falling Thursday. The Massachusetts-based biotech company made two significant announcements regarding its finances and business strategy. What To Know: ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Moderna is investing more than ...
CAMBRIDGE, MA / ACCESS Newswire / November 20, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced it has closed a five-year term loan facility for up to $1.5 billion of capital from Ares Management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results